GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
40.78 +0.10  +0.25% NYSE Apr 27, 16:59 Delayed 2m USD

GlaxoSmithKline Enterprise Value:

122.02B for April 26, 2017
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
April 26, 2017 122.02B
April 25, 2017 123.99B
April 24, 2017 123.10B
April 21, 2017 122.26B
April 20, 2017 122.09B
April 19, 2017 122.41B
April 18, 2017 123.49B
April 17, 2017 124.87B
April 13, 2017 124.80B
April 12, 2017 124.92B
April 11, 2017 124.72B
April 10, 2017 123.54B
April 7, 2017 123.96B
April 6, 2017 123.84B
April 5, 2017 125.09B
April 4, 2017 125.36B
April 3, 2017 125.34B
March 31, 2017 125.66B
March 30, 2017 125.97B
March 29, 2017 126.58B
March 28, 2017 125.79B
March 27, 2017 126.48B
March 24, 2017 125.55B
March 23, 2017 125.55B
March 22, 2017 125.47B
   
March 21, 2017 125.57B
March 20, 2017 125.57B
March 17, 2017 125.45B
March 16, 2017 125.43B
March 15, 2017 124.79B
March 14, 2017 124.12B
March 13, 2017 123.93B
March 10, 2017 123.24B
March 9, 2017 123.44B
March 8, 2017 122.65B
March 7, 2017 123.41B
March 6, 2017 124.35B
March 3, 2017 124.76B
March 2, 2017 123.95B
March 1, 2017 123.26B
Feb. 28, 2017 123.51B
Feb. 27, 2017 123.73B
Feb. 24, 2017 123.71B
Feb. 23, 2017 123.53B
Feb. 22, 2017 122.41B
Feb. 21, 2017 123.88B
Feb. 17, 2017 123.17B
Feb. 16, 2017 122.14B
Feb. 15, 2017 121.28B
Feb. 14, 2017 120.15B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

GSK Enterprise Value Benchmarks

Companies
AstraZeneca 90.01B
Bristol-Myers Squibb 89.11B
Johnson & Johnson 320.04B

GSK Enterprise Value Range, Past 5 Years

Minimum 112.28B Sep 29 2015
Maximum 160.97B Apr 29 2014
Average 135.13B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.